Cronos Group Inc. (CRON) stock analysis

CRON · Cronos Group Inc.

Latest recorded price: USD 3.27

Sector and industry: Healthcare · Drug Manufacturers - Specialty & Generic

Fiscal 2025 figures: revenue growth 16.8%, free cash flow margin 0.1%, ROIC -3.9%. The model flags 1 risk signal for this company.

Similar companies in Healthcare